| AstraZeneca AG - Truqap 160 mg, Filmtabletten | | 69300 | | 01 | | Truqap 160 mg | | Filmtabletten | | L01EX27 | | | | 19.03.2024 | | |
| | Composition | | capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum K 28, macrogolum 3350, polydextrosum, triglycerida media, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Capivasertibum | 160 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Calcium Hydrogenophosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copovidonum K | 28 | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 3350 | | | Magnesii Stearas | | | | Polydextrosum | | | | Pro Compresso Obducto | | | | Triglycerida Media | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 64 | DDP | DDP | A | | Non |
|
|
